3rd Annual Congress of The European Society for Translational Medicine

Vienna, Austria, 1-4 September, 2015



Read in: ch


Keynote Speaker

Adriana Albini

Scientific Director Fondazione Multimedica ONLUS, Milan, Italy

Angiogenesis and the tumor microenvironment as targets for cancer prevention

Keynote Speaker

Ulrich Pfeffer

Head, Functional Genomics lab, National Institute for Cancer Research, IST, Genova, Italy

Susceptibility to breast cancer: from genetics to prevention

Goodwin cutted-1

Thomas J. Goodwin

Member, EUSTM Advisory Board,
Houston, USA

Chair, New Horizons in Biomarkers and Novel Diagnostics
Pic Sinisa Dovat.ashx 1

Sinisa Dovat

Director, Translational Research, Pennsylvania State University, College of Medicine, Pennsylvania, USA

Epigenetic regulation of gene transcription and cell cycle progression by Ikaros in high-risk leukemia‏

Josef Gotzmann

BioOptics facility, MFPL, Vienna Biocenter (VBC), Vienna, Austria

Advanced Light Microscopy: Recent Developments and Applicative Potential for Translational Medicine

Alex Mirnezami

University of Southampton Cancer Sciences Division, Southampton University Hospital NHS Trust, Southampton, UK.

Deregulated stromal and epithelial microRNAs: Role in predicting recurrence in Stage II colorectal cancer‏

Wanmei ou

Oracle Health Sciences, Burlington, MA, USA.

Bridging the Gap between Translational Research and Precision Medicine Clinical Workflow‏

Josie Messina

University of Manchester, Centre for Primary Care, Manchester, UK

The challenges and opportunities for diabetes preventative services in family medicine‏

Aamir Shahzad

President, European Society for translational Medicine (EUSTM),
Vienna, Austria
Chair, New Horizons in Personalized Medicine‏

Roy Goodacre

School of Chemistry, The University of Manchester, Manchester, UK

Human Serum Metabolome in Health and Disease: The Human Serum Metabolome Project‏

Frank Staubli

Nebion AG, Zurich, Switzerland

Identification of genes specifically expressed in Stem Cells using an unbiased data-driven approach‏
Pic F chibon 1

Frédéric Chibon

​INSERM U916 – Institut Bergonié, Bordeaux, France

Beyond the sarcoma genome complexity

Martine J. Jager

​Head, Laboratory of Ophthalmology, Leiden University, The Netherlands.

Correlation between Genetic modifications and inflammation in Uveal Melanoma.

Michael A. Schmidt

Co-chair, Infectious Disease Research Complex, Colorado State University, USA

Space Flight Omics and their Relation to Translational Medicine on Earth

Edwin Bremer

University of Groningen, University Medical Center Groningen (UMCG), Groningen, The Netherlands

Therapeutic exploitation of the cancer glycome; a drug discovery study of the therapeutic potential of the glycan-binding protein galectin-9 for colorectal k-Ras mutant cancer
Picture Tasso R EUSTM

Roberta Tasso

Laboratory of Regenerative Medicine DIMES,University of Genova & A.O.U. San Martino-IST, Genova, Italy

Identification of a New Cell Population Endowed with a Healing Capacity and Constitutively Circulating in Healthy Conditions
pic John P Hays 1

John P. Hays

Erasmus University Medical Centre, Rotterdam, Netherlands

Development of tailored antimicrobial treatment regimens and novel host- pathogen insights for respiratory tract infections and sepsis (TAILORED-Treatment)
Dr. Matthias Nees

Matthias Nees

Turku Centre for Biotechnology, Turku, Finland

Complex Tissue Models that Mimic the Tumour Microenvironment, Heterogeneity, Invasion, Drug Sensitivity and Progression of Cancers
Alessandro Weisz

Alessandro Weisz

Lab. Mol. Medicine and Genomics, University of Salerno,                    Salerno, Italy

Specific PIWI-interacting RNA (piRNA) expression patterns in human cancer
Pic J Sivaraman 1

J Sivaraman

Department of Biological Sciences, National University of Singapore, Singapore

Structural Basis for the Neutralization Mechanism of Hepatitis E Virus by Monoclonal Antibodies

Elizabeth K. Leffel

Leffel Consulting Group, LLC, Terapio, Austin, Texas, USA

Animal Models Characterization: From the Bench to the Bedside

Puthen Veettil Jithesh

PI, Bioinformatics Core, Sidra Medical and Research Center, Doha, Qatar

Experiences and challenges in running a Bioinformatics Core facility
Laurent AUDOLY_IRPF cutted

Laurent Audoly

Senior Vice President R&D, Global Head of Drug Development and Translational Medicine, France

Panelist: New Horizons in drug discovery & development

Alexandre Passioukov

Vice President, Translational Medicine, Pierre Fabre, Toulouse, France

Panelist: New Horizons in Personalized Medicine
pic Marianna bei 1

Marianna Bei

Harvard Medical School & Massachusetts General Hospital, Shriners Burns Hospital Boston, Boston, USA.

Kcnh2 and Kcnj8 Interactively Regulate Skin Wound Healing and Regeneration

Beatrice Bachmeier

Inst. of Laboratory Medicine, Ludwig-Maximilians-University, Munich, Germany

miR181b is induced by the chemopreventive polyphenol curcumin and inhibits breast cancer metastasis via downregulation of the inflammatory cytokines CXCL1 and -2

Araz Raoof

VP, Global Functional Head C.R.E.A.Te Johnson & Johnson, Antwerp, Belgium

The role of biomedical technologies in modern drug discovery and early clinical development

Francisco J. Lopez-Hernandez

University Hospital of Salamanca, IBSAL, Universidad de Salamanca, Salamanca, Spain

Towards an integral diagnostic system for acute kidney injury

Antonio Facchiano

Istituto Dermopatico dell’Immacolata, IDI-IRCCS, Rome, Italy

Analyzing large data-sets. How to organize large sample data-sets and to retrive additional information
Pic Carlos 1

Carlos Martinez Salgado

Instituto de Estudios de Ciencias de la Salud de Castilla y León (IECSCYL), Salamanca, Spain

CT-1 regulates renal fibrosis induced by obstructive nephropathy

Kristina Djinovic-Carugo

Head, Department for Structural and Computational Biology, Max F. Perutz Laboratories, University of Vienna, Austria

Structural basis of myofibrillar myopathies caused by selected filamin mutations

Mauro Cataldi

Department of Neuroscience, Federico II University of Naples, Napoli, Italy.

Autophagy-dependent regulation of tubule formaiton in the brain endothelial cell line bEND.5

Sara Snelling

University of Leeds,
Leeds, UK.

Development of Translatable Region-Specific Molecular Signatures for Sub-Acute Drug Induced Kidney Injury

Erfan Younesi

Fraunhofer Institute for Algorithms & Scientific Computing SCAI, Sankt Augustin, Germany

Translational Bioinformatics in action: Re-defining the Current Diseases Taxonomy
caroline berteau

Caroline Berteau

UCB BioPharma SPRL, Belgium

In vivo/in vitro translation of a molecular signature in the context of preclinical drug-induced kidney injury
Pic Andre De 1

André Nogueira da Costa

Department of Non-Clinical Development, UCB BioPharma SPRL, Belgium

Molecular biomarkers in neurosciences: two-way translational strategies supporting drug development and early disease detection

Daniel Strasser

Senior Lab Head, Translational Science Drug Discovery Biology, Actelion Pharmaceuticals Ltd, Switzerland

Development of a decision-making biomarker for CRTH2 antagonism in clinical studies
image (1)

Rebecca Morris

University of Manchester, Centre for Primary Care, Manchester, UK

The challenges and opportunities for diabetes preventative services in family medicine‏

Tomasz Schneider

Durham University School of Medicine, Pharmacy & Health, Stockton-on-Tees, United Kingdom

Prenatal exposure to Trichostatin A: epigenetic factors and animal models of autism

Zhaohua Zhong

Deputy Dean, Department of Microbiology, Harbin Medical University, Harbin, China

The Role of miR-122 in the Hepatocellular carcinogenesis

2013-2020©European Society for Translational Medicine (EUSTM)

Click to Subscribe to Our Newsletter